Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of TGTX TG Therapeutics | 259.2% in 12m

Compare TGTX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare TG Therapeutics with its related Sector/Index XBI

Compare TG Therapeutics with its related Sector/Index XBI

Performance Duell TGTX vs XBI

TimeFrame TGTX XBI
1 Week 12.5% 2.28%
1 Month -1.29% -1.93%
3 Months 15.5% -0.58%
6 Months 74.6% 15.17%
12 Months 259.2% 45.22%
YTD 44.2% 10.22%
Rel. Perf. 1m -0.10
Rel. Perf. 3m 2.65
Rel. Perf. 6m 3.77
Rel. Perf. 12m 8.53
Spearman 1m -0.70 -0.549
Spearman 3m 0.56 0.010

Is TG Therapeutics a good stock to buy?

Yes, based on ValueRay Fundamental Analyses, TG Therapeutics (NASDAQ:TGTX) is currently (October 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 79.07 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TGTX as of October 2024 is 26.70. This means that TGTX is currently overvalued and has a potential downside of 8.67% (Sold with Premium).

Is TGTX a buy, sell or hold?

  • Strong Buy: 5
  • Buy: 2
  • Hold: 1
  • Sell: 1
  • Strong Sell: 0
TG Therapeutics has received a consensus analysts rating of 4.22. Therefor, it is recommend to buy TGTX.
Values above 0%: TGTX is performing better - Values below 0%: TGTX is underperforming

Compare TGTX with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 11.35% -4.62% 58.97% 222.62%
US NASDAQ 100 QQQ 12.18% -5.16% 60.42% 223.20%
US Dow Jones Industrial 30 DIA 10.90% -4.03% 60.35% 229.92%
German DAX 40 DBXD 10.26% -5.91% 66.88% 228.77%
UK FTSE 100 ISFU 11.62% -0.34% 63.72% 235.03%
Shanghai Shenzhen CSI 300 CSI 300 24.35% -20.09% 63.79% 249.17%
Hongkong Hang Seng HSI 17.14% -12.75% 52.38% 249.55%
Japan Nikkei 225 EXX7 12.60% -5.61% 73.44% 235.95%
India NIFTY 50 INDA 12.64% 0.65% 63.43% 230.31%
Brasil Bovespa EWZ 14.47% 4.04% 79.41% 258.32%

TGTX TG Therapeutics vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 11.84% -5.33% 60.60% 222.26%
Consumer Discretionary XLY 12.05% -4.48% 60.54% 233.04%
Consumer Staples XLP 10.74% 0.29% 60.30% 234.55%
Energy XLE 13.92% -5.85% 78.81% 258.22%
Financial XLF 9.08% -5.68% 56.07% 215.37%
Health Care XLV 11.80% 1.14% 63.53% 239.63%
Industrial XLI 10.51% -6.92% 60.63% 219.83%
Materials XLB 10.50% -4.73% 65.98% 231.79%
Real Estate XLRE 10.31% 0.41% 51.53% 223.41%
Technology XLK 12.17% -5.61% 60.75% 221.85%
Utilities XLU 11.08% -3.84% 46.02% 218.63%
Aerospace & Defense XAR 11.29% -6.45% 53.42% 221.59%
Biotech XBI 10.22% 0.64% 59.46% 213.99%
Homebuilder XHB 11.07% -4.17% 54.00% 188.43%
Retail XRT 10.45% -3.57% 65.02% 229.93%

TGTX TG Therapeutics vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 16.50% -3.94% 85.52% 268.08%
Natural Gas UNG 20.63% 4.43% 75.55% 310.43%
Gold GLD 11.04% -4.33% 63.33% 223.24%
Silver SLV 10.00% -3.57% 65.92% 222.17%
Copper CPER 15.11% -3.62% 74.92% 236.48%

Returns of TGTX vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 12.58% 4.74% 65.72% 242.38%
iShares High Yield Corp. Bond HYG 12.32% -1.48% 66.61% 241.81%
Does TG Therapeutics outperform its market, is TGTX a Sector Leader?
Yes, over the last 12 months TG Therapeutics (TGTX) made 259.21%, while its related Sector, the SPDR S&P Biotech (XBI) made 45.22%.
Over the last 3 months TGTX made 15.51%, while XBI made -0.58%.
Period TGTX XBI S&P 500
1 Month -1.29% -1.93% 3.33%
3 Months 15.51% -0.58% 3.57%
12 Months 259.21% 45.22% 36.59%